Yale School of Medicine, New Haven, Connecticut, USA.
Yale J Biol Med. 2011 Jun;84(2):125-9.
Over the past 200 years, there have been countless groundbreaking discoveries in biology and medicine at Yale University. However, one particularly noteworthy discovery with profoundly important and broad consequences happened here in just the past two decades. In 2009, Thomas Steitz, the Sterling Professor of Molecular Biophysics & Biochemistry, was awarded the Nobel Prize in Chemistry for "studies of the structure and function of the ribosome," along with Venkatraman Ramakrishnan of the MRC Laboratory of Molecular Biology and Ada E. Yonath of the Weizmann Institute of Science. This article covers the historical context of Steitz's important discovery, the techniques his laboratory used to study the ribosome, and the impact that this research has had, and will have, on the future of biological and medical research.
在过去的 200 年里,耶鲁大学在生物学和医学领域取得了无数开创性的发现。然而,就在过去的二十年里,这里发生了一项特别值得注意的发现,其具有深远的重要意义和广泛的影响。2009 年,斯特林分子生物物理学和生物化学教授托马斯·斯蒂茨(Thomas Steitz)因“核糖体结构和功能的研究”与英国医学研究理事会分子生物学实验室的文卡特拉曼·拉马克里希南(Venkatraman Ramakrishnan)和魏茨曼科学研究所的阿达·约纳特(Ada E. Yonath)一起获得诺贝尔化学奖。本文涵盖了斯蒂茨重要发现的历史背景、他的实验室用来研究核糖体的技术,以及这项研究对生物和医学研究的未来产生的、并将继续产生的影响。